New Study on Kids' COVID: Hearts Safe, but Lingering Symptoms Are Real

WASHINGTON, DC – May 28, 2026 – A sweeping new study from Children’s National Hospital and the National Institutes of Health (NIH) is providing one of the clearest pictures yet of COVID-19's long-term effects on children, delivering a mix of reassuring news for worried parents and critical data on a host of lingering symptoms.

The research, emerging from the Pediatric COVID Outcomes Study (PECOS), offers a landmark analysis that helps untangle the direct impact of the virus from the widespread stress of the pandemic itself. The findings confirm that while a majority of children experienced mild illness, a significant subset endures persistent issues, while also providing powerful evidence that long-term heart damage from the virus is not a primary concern for most.

A New Map for a Mysterious Condition

As the first and largest U.S. study to publish long-term, follow-up data on pediatric COVID-19, the PECOS research provides a crucial roadmap for families and clinicians navigating post-viral symptoms. Researchers tracked hundreds of children for up to a year, meticulously comparing those who had COVID-19 with a control group of those who had not.

The investigation identified 20 specific symptoms that were more common in children who had been infected. This list includes familiar post-viral complaints such as fatigue, headaches, and respiratory issues, but also more subtle and disruptive problems like forgetfulness, gastrointestinal distress, and a general feeling of unwellness or malaise. These symptoms, the study found, can follow a complex timeline.

“This study helps us understand how post-COVID symptoms in children evolve over time, and importantly, across different age groups,” said Dr. Alexandra Yonts, an infectious diseases specialist at Children’s National and a co-lead author of the study. “Since childhood is such a dynamic period of growth and development, tracking these symptoms at multiple time points and in children of many different ages is critical to know what the true long-term impacts of SARS-CoV-2 infection look like in the pediatric population.”

Children who had contracted the virus reported worse overall health, diminished physical and cognitive functioning, and greater struggles with pain and sleep disturbances compared to their uninfected peers. The findings underscore that even after a seemingly mild infection, the road to full recovery can be long and uneven for some children.

The Long COVID Landscape: A Complex Picture

The PECOS findings land in a scientific landscape where understanding of pediatric long COVID is still evolving. While the study provides a strong, clear signal, its results also highlight the complexity of defining and diagnosing the condition. Prevalence estimates from various studies have differed significantly, sowing confusion for the public.

Data from the Centers for Disease Control and Prevention (CDC) has previously characterized long COVID as relatively rare in children, with surveys suggesting around 1.4% of U.S. children experienced the condition in 2023. However, other research, including studies published in JAMA Pediatrics, has suggested the condition could be far more common, potentially affecting 10-20% of infected children and creating distinct symptom patterns in different age groups, from sleep disturbances in toddlers to fatigue and brain fog in teens.

What makes the PECOS study so valuable is its rigorous, longitudinal design, comparing infected children to a control group over an extended period. This methodology helps isolate the symptoms truly associated with the virus. The study’s authors noted that their cohort consisted mainly of children with mild initial infections, which reflects the most common experience during the pandemic.

“This study included mostly children with mild COVID-19 similar to what was seen during the pandemic period and results should be interpreted accordingly,” cautioned Dr. Gina Montealegre Sanchez of the NIH’s National Institute of Allergy and Infectious Diseases (NIAID), a co-principal investigator of the study.

Reassurance for the Heart

Perhaps the most significant and welcome news from the research comes from a deep dive into cardiovascular health. Early in the pandemic, concerns about heart inflammation (myocarditis) and other cardiac complications were prominent. In a major point of reassurance, the PECOS study found no evidence that COVID-19 causes long-term heart damage in children.

Using advanced cardiac imaging, researchers observed no difference in heart function between children who had COVID-19 and those who had not. Crucially, this held true even for children reporting symptoms often associated with heart issues, such as chest pain and fatigue.

“While some children experience these seemingly cardiac symptoms, our findings show these are not linked to underlying heart dysfunction,” explained Dr. Michael He, a cardiology fellow at Children’s National and an author on the cardiac portion of the research.

This finding aligns with general statements from the American Heart Association, which has noted a low risk of heart issues for most children post-infection. It helps distinguish the direct effects of the virus from Multisystem Inflammatory Syndrome in Children (MIS-C), a rare but serious post-COVID condition known to affect the heart, from which most children also recover good cardiac function.

Beyond the Virus: The Pandemic’s Shared Burden

While the study detailed the physical toll of the virus, it also uncovered a profound truth about the pandemic's psychological impact. Researchers found that rates of anxiety and depression were similar between children who had been infected with COVID-19 and those who had not. This suggests that the mental health crisis among youth is a shared burden of the pandemic era, affecting an entire generation regardless of their infection status.

Disruptions to school, social isolation, and family stress created a high-pressure environment that took a toll on children everywhere. The findings validate the experiences of parents, educators, and mental health professionals who have witnessed a surge in mental health challenges among young people.

“The pandemic has affected all children’s mental health, not just those who were infected,” stated Dr. Linda Herbert, director of Psychology Research and Clinical Services at Children’s National. “These findings highlight the broad impact of this experience on an entire generation.”

This aspect of the study provides critical context, helping to differentiate symptoms of a direct viral infection from the broader psychological fallout of living through a global crisis. It reinforces the need for widespread mental health support for all children as they continue to navigate the pandemic's long shadow.

A Clearer Path for Parents and Pediatricians

Ultimately, the comprehensive data from the PECOS study provides a clearer path forward. By identifying specific, persistent symptoms while simultaneously debunking fears of widespread long-term heart damage, the research equips pediatricians to better screen, diagnose, and manage post-COVID conditions.

This evidence-based guidance will help clinicians reassure families about cardiac concerns while taking other persistent symptoms like fatigue and cognitive issues seriously. It supports existing recommendations from groups like the American Academy of Pediatrics (AAP) for follow-up care and screening for all children after a COVID-19 diagnosis.

By helping to distinguish the direct effects of the virus from the pandemic's broader societal impact, this research empowers both doctors and parents to make more informed decisions, ensuring that children receive the targeted support they need to recover fully and thrive.